Erysimoside

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 464301

CAS#: 7082-34-0

Description: Erysimoside is a cardenolide glycoside that consists of strophanthidin having a beta-D-glucopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl moiety attached at position 3. It is a 14beta-hydroxy steroid, a 19-oxo steroid, a 5beta-hydroxy steroid, a cardenolide glycoside, a steroid saponin and a steroid aldehyde. It derives from a strophanthidin.

Chemical Structure

img
Erysimoside
CAS# 7082-34-0
Instruction

Theoretical Analysis

MedKoo Cat#: 464301
Name: Erysimoside
CAS#: 7082-34-0
Chemical Formula: C35H52O14
Exact Mass: 696.34
Molecular Weight: 696.787
Elemental Analysis: C, 60.33; H, 7.52; O, 32.15

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: Erysimoside; Erizimoside; Neoglucoerysimoside;

IUPAC/Chemical Name: (3S,5S,8R,9S,10S,13R,14S,17R)-5,14-dihydroxy-3-(((2R,4S,5S,6R)-4-hydroxy-6-methyl-5-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-13-methyl-17-(5-oxo-2,5-dihydrofuran-3-yl)hexadecahydro-10H-cyclopenta[a]phenanthrene-10-carbaldehyde

InChi Key: KQBVSIZPUWODNU-VRQSBXMXSA-N

InChi Code: InChI=1S/C35H52O14/c1-17-30(49-31-29(42)28(41)27(40)24(14-36)48-31)23(38)12-26(46-17)47-19-3-8-33(16-37)21-4-7-32(2)20(18-11-25(39)45-15-18)6-10-35(32,44)22(21)5-9-34(33,43)13-19/h11,16-17,19-24,26-31,36,38,40-44H,3-10,12-15H2,1-2H3/t17-,19+,20-,21+,22-,23+,24-,26+,27-,28+,29-,30-,31+,32-,33+,34+,35+/m1/s1

SMILES Code: C[C@H]1O[C@@H](O[C@H]2CC[C@@]3([C@H]4CC[C@@]5([C@@H](C6=CC(OC6)=O)CC[C@@]5([C@@H]4CC[C@@]3(C2)O)O)C)C=O)C[C@@H]([C@@H]1O[C@@H]7O[C@@H]([C@H]([C@@H]([C@H]7O)O)O)CO)O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: To be determined

Shelf Life: >2 years if stored properly

Drug Formulation: To be determined

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 696.79 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Grosa G, Allegrone G, Del Grosso E. LC-ESI-MS/MS characterization of strophanthin-K. J Pharm Biomed Anal. 2005 Jun 1;38(1):79-86. doi: 10.1016/j.jpba.2004.12.008. Epub 2005 Jan 19. PMID: 15907623.

2: Lei ZH, Kuniyasu A, Tai BS, Nakayama H, Nohara T. Na+,K(+)-ATPase inhibiting activity of cardiac glycosides from Erysimum cheiranthoides. Planta Med. 2001 Jun;67(4):369-70. doi: 10.1055/s-2001-14309. PMID: 11458460.

3: Hugentobler U, Renwick JA. Effects of plant nutrition on the balance of insect relevant cardenolides and glucosinolates in Erysimum cheiranthoides. Oecologia. 1995 Apr;102(1):95-101. doi: 10.1007/BF00333315. PMID: 28306812.

4: Huang X, Renwick JA. Cardenolides as oviposition deterrents to twoPieris species: Structure-activity relationships. J Chem Ecol. 1994 May;20(5):1039-51. doi: 10.1007/BF02059740. PMID: 24242301.

5: Huang X, Renwick JA, Sachdev-Gupta K. A chemical basis for differential acceptance ofErysimum cheiranthoides by twoPieris species. J Chem Ecol. 1993 Feb;19(2):195-210. doi: 10.1007/BF00993689. PMID: 24248868.

6: Sachdev-Gupta K, Renwick JA, Radke CD. Isolation and identification of oviposition deterrents to cabbage butterfly,Pieris rapae, fromErysimum cheiranthoides. J Chem Ecol. 1990 Apr;16(4):1059-67. doi: 10.1007/BF01021010. PMID: 24263711.

7: Novye preparaty: érizimozid--serdechmyĭ glikozid [New preparations: erysimoside, a cardiac glycoside]. Farmatsiia. 1975 Jul-Aug;24(4):91-2. Russian. PMID: 1218612.

8: TUROVA AD. NOVY I SERDECHNY I GLIUKOZID 'ERIZIMOZID [A NEW CARDIAC GLYCOSIDE ERYSIMOSIDE]. Farmakol Toksikol. 1964 Sep-Oct;27:561-4. Russian. PMID: 14264100.